- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Phio Pharmaceuticals (PHIO)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 10.71 mm | 10.71 mm | 10.71 mm | 10.71 mm | 10.71 mm | 10.71 mm |
| Cash burn (monthly) | 23.33 k | (no burn) | 835.00 k | 696.67 k | 695.00 k | 605.92 k |
| Cash used (since last report) | 56.40 k | n/a | 2.02 mm | 1.68 mm | 1.68 mm | 1.46 mm |
| Cash remaining | 10.65 mm | n/a | 8.69 mm | 9.02 mm | 9.02 mm | 9.24 mm |
| Runway (months of cash) | 456.4 | n/a | 10.4 | 12.9 | 13.0 | 15.3 |
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 3 |
| Increased positions | 0 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 758.00 k |
| Total shares | 274.10 k |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| CVI Investments | 228.90 k | $616.00 k |
| Intracoastal Capital | 45.21 k | $142.00 k |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Nov 25 | Robert J Bitterman | Common Stock, $.0001 par value | Buy | Acquire P | No | No | 1.14 | 5,000 | 5.70 k | 281,421 |
| 18 Nov 25 | Robert J Bitterman | Common Stock, $.0001 par value | Buy | Acquire P | No | No | 1.27 | 5,000 | 6.35 k | 276,421 |
| 11 Sep 25 | Robert J Bitterman | Common Stock, $.0001 par value | Grant | Acquire A | No | No | 0 | 250,000 | 0.00 | 271,421 |
| 11 Sep 25 | Robert J Bitterman | Common Stock, $.0001 par value | Payment of exercise | Dispose F | No | No | 2.32 | 4,111 | 9.54 k | 21,421 |
| 11 Sep 25 | Lisa Cabott Carson | Common Stock, $.0001 par value | Grant | Acquire A | No | No | 0 | 47,000 | 0.00 | 47,000 |
| 11 Sep 25 | Patricia A Bradford | Common Stock, $.0001 par value | Grant | Acquire A | No | No | 0 | 18,800 | 0.00 | 27,151 |